NANOMEDICINE

Nanomedicine Workshop provides medical doctors, engineers, scientists, new researchers and stakeholders from different disciplines with a unique and exciting format to learn the most current information about nanomedicine advances in the early diagnosis and treatment of diseases. It will be a perfect platform to share, experience, foster collaborations across health care, pharmaceutical, biotech & diagnostic industries with hospitals and academia.

There is an enormous gap between clinical practice and Nanosciences & Nanotechnologies. This workshop attempts to fill this gap more perfectly and more currently by enlisting world-renowned speakers and stakeholders in Nanomedicine with up-to-date information towards unmet clinical needs. It will feature a scientific program of comprehensive talks, special sessions, debates, oral and poster presentations of peer-reviewed contributions to showcase the most recently breaking research development, discovery, industrial progress and milestones in Nanomedical, Nanobiotechnology, Regenerative Medicine and Nanopharmaceutics R & D.

Nanomedicine Workshop will address progress and prospects for nanomedicine including, in-vitro and in-vivo diagnostics, biosensors, imaging, targeted drug delivery, nanomaterials, regenerative medicine. Updates on preclinical and clinical trials, clinical hurdles in a wide spectrum of diseases (Oncology, Cardiovascular Disease, Orthopaedics, Neurodegenerative, Infections, Diabetes, Ophthalmology, etc) and nanomedicine- oriented solutions will be presented. Nanotoxicology and ethics will constitute the controversial issues to be discussed.

Together with the co-located Bioelectronics Workshop, it will provide the latest advances in biosensors and bioactuators from bench to bedside. Fundamentals of biosensor design and manufacturing will be covered and translated into clinical applications.

The Nanomedicine Workshop covers (but not limited to) the following key topics:

Basics related to Medicine, Biology, and Nanotechnology

• Nanotechnology in Biology
• Biological Systems (from biomolecules to cells and organisms) and Biological Structures
• Self-assembly and self-organization
• Nanobiotechnology
• Nanotechnology for Health and Food products
• Cell/Nanomaterial Interactions
• Biomechanics

Nanobiomedicine

• Nanoimaging and therapy
• Nanoinformatics
• Clinical Nanomedicine
• Nanomedicine-based cancer immunotherapy
• Stimuli-responsive nanosystems
• CRISPR-Cas NPs in cancer immunotherapy
• Biomimetic NPs for cancer immunotherapy

Nanomaterials for Bio-Applications

• Nanostructures for medical applications
• Nanofibres, Nanoparticles, and Nanotubes

Clinical Applications

• Versatile Nanotech tools and nanomaterials in Medicine
• Biomaterials and Nanomaterials for biosensing, imaging, diagnostic and vectorization
• In-vivo Diagnostics and imaging
• Targeted Drug Delivery
• Regenerative Nanomedicine
• Stem Cells, Cellular & Tissue Engineering
• Nanodrugs and Nanopharmacy
• Nano-Cosmetics
• Nanodentistry
• Nanomedicine Targeting Major Diseases

Update on Preclinical and Clinical trials on Nanomedicine

Nanotoxicity, Risk Assessment and Ethics

Commercialization in Nanomedicine

Special Session on Law and ethics of nanotechnology safety and health in food

Thursday 6th of July

Dedicating a science conference session for the first time to the non- science topic of Law and Ethics represents an important recognition by researchers of their need to learn about and participate as stakeholders in nanotechnology law and ethics programming. The session's focus on safety and health represents a nod to the transversal implications of crosscutting law and ethics issues that have historically been undervalued by the scientific community. Discussing these aspects of nanostructures in food is the perfect vehicle for targeting the underlying value of law and ethical concerns because everyone eats and every nation has laws about food. Thus starting with nanostructures in food is a unifying denominator that overcomes barriers such as age race nationality or gender preference, which too often appear as a threshold impediment to meaningful academic discourse. Food safety and global health are also important aspects of how nanotechnology touches everyone in daily life.

Session Chair Dr Ilise Feitshans

Speakers

Dr John Howard, Director of NIOSH USA
Dr Ilise Feitshans, Georgetown University Law Center Washington DC USA
John Koehler, Esq. Executive Director Virginia Mountain Valley Lawyers Alliance USA
Dr Chrisa Bassara, MD Cardiologist Greece

 

WORKSHOP 3 COMMITTEE (tentative)

V. Karagkiozaki (Chair), Nanotechnology Lab LTFN and AHEPA Hospital AUTh, Greece
T. Mitsiadis (co-Chair), Uni of Zurich, Switzerland
A. Alexandrou, Lab for Optics & Biosciences, Ecole Polytechnique, France
N. Baldini, Uni of Bologna and Istituto Ortopedico Rizzoli, Italy
L. P. Balogh, Precision Nanomedicine, USA
E. Chang, Dept of Oncology, Lombardi Comprehensive Cancer Center, Georgetown Uni, USA
Th. Choli – Papadopoulou, Chemistry Dept, AUTh, Greece
G. Kousoulas, Division of Biotechnology & Molecular Medicine, Louisiana State Uni, USA
M. Masserini, Medical School- Uni of Milan Bicocca, Italy
H. J. Meisel, Department of Neurosurgery, BG-Clinic Bergmannstrost, Germany
Y. Missirlis, Lab of Biomechanics & Biomedical Engineering, Uni of Patras, Greece
A. Mikos, Rice Uni, USA
M. Tanaka, Kyushu Uni & Uni of Yamagata, Japan

---

Organized by:

	EU H2020-FlexFunction2Sustain: "Open Innovation Ecosystem for Sustainable Nano-functionalized Flexible Plastic and Paper Surfaces and Membranes" www.flexfunction2sustain.eu

Supported by: